5.Diabetes Canada Clinical Practice Guidelines Expert Committee
In August 2025, the Food and Drug Administration (FDA) also approved semaglutide for the treatment of MASH with moderate or advanced fibrosis [14] based on the results of a published trial [15]
Modifying a workout due to fatigue 31 or choosing different foods due to nausea 73 should be seen as strategic adaptations to maintain long-term adherence and progress, rather than setbacks
The obesity epidemic is a major public health issue that has escalated over many decades
none is approved as a study aid Side effects across all three include appetite suppression, insomnia, elevated heart rate, and potential rebound symptoms Using any prescription stimulant without a diagnosis and prescription is illegal and carries unmonitored health risk No food supplement replicates the mechanism of a prescription stimulant
Individual results vary based on starting weight, dose, response, and lifestyle alongside the medication
.webp)
